Concepedia

Tomas Fex

TF

Statistics

Publications

22

Citations

986

H-Index

16

Active since

1976

Affiliations

AstraZeneca (Sweden)(Current)

Umeå University

Active Biotech (Sweden)

Lund University

Linnaeus University

Tomas Fex is an author at AstraZeneca (Sweden) specializing in drug discovery, pharmacy, and medicinal chemistry.

Publications per year

1976–2020

22

Publications

22

Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship

Stig Jönsson, Gunnar Andersson, Tomas Fex et al. · Journal of Medicinal Chemistry · 2004 · 157 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Design and Evaluation of Pilicides: Potential Novel Antibacterial Agents Directed Against UropathogenicEscherichia coli

Anette Svensson, Andréas Larsson, Hans Emtenäs et al. · ChemBioChem · 2001 · 135 citations

Pharmacy, Infectious Diseases, Microbiology +11

Clavatadine A, A Natural Product with Selective Recognition and Irreversible Inhibition of Factor XIa

Malcolm S. Buchanan, Anthony R. Carroll, Deborah Wessling et al. · Journal of Medicinal Chemistry · 2008 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Weak affinity chromatography as a new approach for fragment screening in drug discovery

Minh‐Dao Duong‐Thi, Elinor Meiby, Maria Bergström et al. · Analytical Biochemistry · 2011 · 74 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Use of 19F NMR spectroscopy to evaluate reactions in solid phase organic synthesis

Anette Svensson, Tomas Fex, Jan Kihlberg · Tetrahedron Letters · 1996 · 61 citations

Natural Sciences, Chemistry, Organic Chemistry +10

1–5 of 22